Semaglutide/GLP-1 administered through once-weekly injections beginning at 0.25 mg for the first month
American Journal of Cardiovascular Drugs, 16 (5), 355-365
Unlike retail pharmacies, PlexusDx eliminates middleman markups and rebate structures, passing substantial savings directly to patients
Clinical trials show that approximately 14% of patients taking Wegovy experience headaches, compared to 10% on placebo
Consult a healthcare practitioner prior to use if you are pregnant or breastfeeding, if you have liver or kidney disease, you have a pre-existing medical disorder or if you have been instructed to follow a low-protein diet
The batch-specific CoA for BPC-157 + TB-500 shows an HPLC purity of 99% or higher, identity confirmation via mass spectrometry, the batch number and the net peptide content in milligrams per vial